These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. Asayama Y; Tajima T; Nishie A; Ishigami K; Kakihara D; Nakayama T; Okamoto D; Fujita N; Aishima S; Shirabe K; Honda H Eur J Radiol; 2011 Dec; 80(3):e243-8. PubMed ID: 21109378 [TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659 [TBL] [Abstract][Full Text] [Related]
25. Primovist, Eovist: what to expect? Van Beers BE; Pastor CM; Hussain HK J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332 [TBL] [Abstract][Full Text] [Related]
26. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540 [TBL] [Abstract][Full Text] [Related]
27. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. Ni Y; Marchal G; Yu J; Mühler A; Lukito G; Baert AL J Magn Reson Imaging; 1994; 4(3):355-63. PubMed ID: 8061434 [TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513 [TBL] [Abstract][Full Text] [Related]
30. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms. Ying SH; Teng XD; Wang ZM; Wang QD; Zhao YL; Chen F; Xiao WB World J Gastroenterol; 2015 Jul; 21(25):7824-33. PubMed ID: 26167082 [TBL] [Abstract][Full Text] [Related]
31. Dynamic MR imaging of kidneys perfused with EOB-Gd-DTPA. Hyodoh K; Hyodoh H; Kasahara M; Washio Y; Asai M; Hareyama M Acta Chir Iugosl; 2011; 58(1):29-32. PubMed ID: 21630549 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
33. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats. Mühler A; Heinzelmann I; Weinmann HJ Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100 [TBL] [Abstract][Full Text] [Related]
34. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695 [TBL] [Abstract][Full Text] [Related]
35. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Tsuda N; Okada M; Murakami T Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431 [TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473 [TBL] [Abstract][Full Text] [Related]
37. Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Sato T; Tamada T; Watanabe S; Nishimura H; Kanki A; Noda Y; Higaki A; Yamamoto A; Ito K Radiol Med; 2015 Jun; 120(6):557-62. PubMed ID: 25572545 [TBL] [Abstract][Full Text] [Related]
38. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol. Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296 [TBL] [Abstract][Full Text] [Related]
39. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. Runge VM J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461 [TBL] [Abstract][Full Text] [Related]